Indications & Dose:
Primary immunisation against Neisseria meningitidis
Child 13–15 years: 0.5 mL for 1 dose, dose preferably injected into deltoid region
Immunisation against Neisseria meningitidis in an unimmunised patient
Child 10–17 years: 0.5 mL for 1 dose, booster dose is not required
Adult 18–24 years: 0.5 mL for 1 dose, booster dose is not required
Immunisation against Neisseria meningitidis in those at risk of exposure to prevent invasive disease
Child 3–11 months: 0.5 mL every month for 2 doses, dose preferably injected into deltoid region
Child 1–17 years: 0.5 mL for 1 dose, dose preferably injected into deltoid region Adult: 0.5 mL for 1 dose, dose preferably injected into deltoid region
Patients attending university for the first time (who have not received the routine meningococcal A, C,W135, and Y conjugate vaccine over the age of 10 years)
Adult 18–24 years: 0.5 mL for 1 dose continued’!
Primary immunisation against Neisseria meningitidis
Child 13–15 years: 0.5 mL for 1 dose, to be injected preferably into deltoid region
Immunisation against Neisseria meningitidis in an unimmunised patient
Child 10–17 years: 0.5 mL for 1 dose, booster dose is not required
Adult 18–24 years: 0.5 mL for 1 dose, booster dose is not required
Immunisation against Neisseria meningitidis in those at risk of exposure
Child 1–17 years: 0.5 mL for 1 dose, to be injected preferably into deltoid region (or anterolateral thigh in child 12–23 months), then 0.5 mL after 1 year if required for 1 dose, second dose should be considered in those who continue to be at risk of Neisseria meningitidis serogroup A infection
Adult: 0.5 mL for 1 dose, to be injected preferably into deltoid region, then 0.5 mL after 1 year if required for 1 dose, second dose should be considered in those who continue to be at risk of Neisseria meningitidis serogroup A infection
Patients attending university for the first time (who have not received the routine meningococcal A, C,W135, and Y conjugate vaccine over the age of 10 years)
Adult 18–24 years: 0.5 mL for 1 dose
Contraindications:
Side Effects:
Rare Symptoms of meningitis reported (but no evidence that the vaccine causes meningococcal C meningitis)
Cautions:
Precautions:
Interaction:
Warnings:
Adverse Effects:
Lactations:
Special Precautions:
Counselling:
Side Effects Or Adverse Reactions:
Patient And Carer Advice:
© Pakistan Drug Directory. All Rights Reserved.
Designed By: Pakistan Drug Directory Team